AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36330537 — intervention group
Group type: EXPERIMENTAL
Intervention: Postpartum IUD (PPIUD) intervention
Number of subjects: 19431
Study 36053364 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 g kg-1 body mass NaHCO3 in chilled orange squash
Number of subjects: 28
Study 36053364 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 g kg-1 body mass NaHCO3 in capsules
Number of subjects: 28
Study 36053364 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.03 g kg-1 body mass sodium chloride)
Number of subjects: 28
Study 33468147 — intervention group
Group type: EXPERIMENTAL
Intervention: artemether-lumefantrine (AL)
Number of subjects: 720
Study 33468147 — intervention group
Group type: EXPERIMENTAL
Intervention: dihydroartemisinin-piperaquine (DP)
Number of subjects: 720
Study 35654932 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus acidophilus consumption
Number of subjects: 107
Study 35654932 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study 32835786 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (24 IU)
Number of subjects: 73
Study 32835786 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study 36011834 — intervention group
Group type: EXPERIMENTAL
Intervention: Martial Arts Sensory Teaching Group (MAST)
Number of subjects: 87
Study 36011834 — intervention group
Group type: EXPERIMENTAL
Intervention: Martial Arts Traditional Teaching Group (MATT)
Number of subjects: 87
Study 36011834 — intervention group
Group type: COMPARATOR
Intervention: Free Activity Group (FA)
Number of subjects: 87
Study 32143063 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual-manual SRTT
Number of subjects: 0
Study 32143063 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-choice task
Number of subjects: 0
Study 36160279 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin
Number of subjects: 270
Study 36160279 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 270
Study 33830626 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin degludec 100 units/mL (degludec)
Number of subjects: 8355
Study 33830626 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine 100 units/mL (glargine U100)
Number of subjects: 8355
Study 33825140 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin-K1 [10 mg/day]
Number of subjects: 154
Study 33825140 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine [0.5 mg/day]
Number of subjects: 154
Study 33825140 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 154
Study 34916643 — intervention group
Group type: EXPERIMENTAL
Intervention: Four-implant overdentures in the maxilla
Number of subjects: 24
Study 33202169 — intervention group
Group type: EXPERIMENTAL
Intervention: Domperidone (10 mg, 2 tablets three times a day for 14 days)
Number of subjects: 47
Study 33202169 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study 32200486 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy plus metformin
Number of subjects: 126
Study 32200486 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 126
Study 32200486 — intervention group
Group type: EXPERIMENTAL
Intervention: CTC count
Number of subjects: 126
Study 33586367 — intervention group
Group type: EXPERIMENTAL
Intervention: Inosine
Number of subjects: 120
Study 33586367 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 33046584 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based tailored messaging intervention (VAYB)
Number of subjects: 824
Study 33046584 — intervention group
Group type: COMPARATOR
Intervention: Untailored version of the intervention (UT)
Number of subjects: 824
Study 33046584 — intervention group
Group type: COMPARATOR
Intervention: Usual care intervention (UC)
Number of subjects: 824
Study 33046584 — intervention group
Group type: COMPARATOR
Intervention: Comparison of VAYB to UC
Number of subjects: 824
Study 33046584 — intervention group
Group type: COMPARATOR
Intervention: Comparison of VAYB to UT
Number of subjects: 824
Study 33046584 — intervention group
Group type: COMPARATOR
Intervention: Comparison of UT to UC
Number of subjects: 824
Study 35723054 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking Football (WF) program during Ramadan fasting (RF)
Number of subjects: 31
Study 35723054 — intervention group
Group type: COMPARATOR
Intervention: Control group (participated in Ramadan fasting)
Number of subjects: 31
Study 34167566 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile blood pressure management application
Number of subjects: 120
Study 33376177 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth-delivered physical activity programme
Number of subjects: 0
Study 33376177 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 0
Study 35092760 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper limb RIPC
Number of subjects: 345
Study 35092760 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower limb RIPC
Number of subjects: 345
Study 35092760 — intervention group
Group type: COMPARATOR
Intervention: Upper limb control
Number of subjects: 345
Study 35092760 — intervention group
Group type: COMPARATOR
Intervention: Lower limb control
Number of subjects: 345
Study 34315695 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic treatment (2 g sachet daily)
Number of subjects: 80
Study 34315695 — intervention group
Group type: COMPARATOR
Intervention: Control group (no probiotic supplements)
Number of subjects: 80
Study 36402160 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous infusion of foslevodopa-foscarbidopa plus oral placebo capsules
Number of subjects: 141
Study 32468645 — intervention group
Group type: EXPERIMENTAL
Intervention: Talazoparib
Number of subjects: 0
Study 35560315 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortified BEP supplements and IFA
Number of subjects: 1897
Study 35560315 — intervention group
Group type: COMPARATOR
Intervention: IFA
Number of subjects: 1897
Study 33792019 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interventions and mobile social network support for three months
Number of subjects: 121
Study 33792019 — intervention group
Group type: COMPARATOR
Intervention: Regular care and a smoking cessation booklet
Number of subjects: 121
Study 33792019 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group
Number of subjects: 121
Study 33792019 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 121
Study 34938352 — intervention group
Group type: EXPERIMENTAL
Intervention: Nanosilver Burn Dressing (NSBD)
Number of subjects: 106
Study 34938352 — intervention group
Group type: COMPARATOR
Intervention: Sulfadiazine Silver Cream (SSC)
Number of subjects: 106
Study 32869324 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospitalization due to bleeding-related reasons
Number of subjects: 22429
Study 32869324 — intervention group
Group type: EXPERIMENTAL
Intervention: Switching from warfarin to a direct oral anticoagulant after hospitalization
Number of subjects: 22429
Study 32869324 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospitalization (general)
Number of subjects: 22429
Study 33814028 — intervention group
Group type: EXPERIMENTAL
Intervention: MenACYW-TT
Number of subjects: 1183
Study 33814028 — intervention group
Group type: COMPARATOR
Intervention: MenACYW-TT + MMR + V
Number of subjects: 1183
Study 33814028 — intervention group
Group type: COMPARATOR
Intervention: MenACYW-TT + DTaP-IPV-HepB-Hib
Number of subjects: 1183
Study 33814028 — intervention group
Group type: COMPARATOR
Intervention: MenACYW-TT + PCV13
Number of subjects: 1183
Study 33814028 — intervention group
Group type: COMPARATOR
Intervention: MMR + V, DTaP-IPV-HepB-Hib, and PCV13
Number of subjects: 1183
Study 35997810 — intervention group
Group type: EXPERIMENTAL
Intervention: EX‐PLISSIT‐based counseling sessions for 4 weeks
Number of subjects: 110
Study 35997810 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 110
Study 34611701 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative MRI
Number of subjects: 440
Study 34611701 — intervention group
Group type: COMPARATOR
Intervention: Conventional imaging (Control)
Number of subjects: 440
Study 32873251 — intervention group
Group type: EXPERIMENTAL
Intervention: 5Gy x 5 fractions of short-course radiation therapy (SCRT) followed by 6 cycles of mFOLFOX-6 plus avelumab
Number of subjects: 44
Study 34742317 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined exercise (60 min of aerobic and resistance exercise three times/week for 12 weeks)
Number of subjects: 30
Study 34742317 — intervention group
Group type: COMPARATOR
Intervention: Control (no exercise)
Number of subjects: 30
Study 32589286 — intervention group
Group type: EXPERIMENTAL
Intervention: Red blood cell (RBC) transfusion
Number of subjects: 5604984
Study 32589286 — intervention group
Group type: EXPERIMENTAL
Intervention: RBC transfusion
Number of subjects: 5604984
Study 32589286 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma transfusion
Number of subjects: 5604984
Study 32589286 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet transfusion
Number of subjects: 5604984
Study 34518988 — intervention group
Group type: EXPERIMENTAL
Intervention: Tislelizumab (monoclonal antibody)
Number of subjects: 248
Study 32993766 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBOT) in addition to standard treatment (dressings, debridement, antibiotics, load relief)
Number of subjects: 120
Study 32993766 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (dressings, debridement, antibiotics, load relief)
Number of subjects: 120
Study 32993766 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups will complete the SF-36 quality of life questionnaire upon admission and after 3 months of follow-up.
Number of subjects: 120
Study 35331180 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal-transhiatal (TH) approach
Number of subjects: 312
Study 35331180 — intervention group
Group type: COMPARATOR
Intervention: Right thoracoabdominal (RTA) approach
Number of subjects: 312
Study 33198700 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 144
Study 33198700 — intervention group
Group type: COMPARATOR
Intervention: Control (self-help materials only)
Number of subjects: 144
Study 36480101 — intervention group
Group type: EXPERIMENTAL
Intervention: 4–7–8 breathing technique
Number of subjects: 90
Study 36480101 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep breathing exercise
Number of subjects: 90
Study 36480101 — intervention group
Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 90
Study 34757573 — intervention group
Group type: EXPERIMENTAL
Intervention: Training of frontline workers (FLWs) using a training module developed in regional language.
Number of subjects: 1717
Study 34757573 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training provided to FLWs).
Number of subjects: 1717
Study 33179247 — intervention group
Group type: COMPARATOR
Intervention: Rufinamide (add-on treatment)
Number of subjects: 1759
Study 35015365 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-Help Plus (combined with Enhanced Care as Usual)
Number of subjects: 642
Study 35015365 — intervention group
Group type: COMPARATOR
Intervention: Enhanced Care as Usual (ECAU)
Number of subjects: 642
Study 35015365 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-Help Plus
Number of subjects: 642
Study 34231473 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 L of polyethylene glycol (PEG)/ascorbic acid booster solution after the capsule reached the small intestine (group 2)
Number of subjects: 166
Study 34231473 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 L of polyethylene glycol (PEG)/ascorbic acid booster solution after the capsule reached the small intestine (group 3)
Number of subjects: 166
Study 34231473 — intervention group
Group type: COMPARATOR
Intervention: Clear liquid diet and fasting-based bowel preparation (group 1)
Number of subjects: 166
Study 32304596 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Index (RI) in anterior cerebral artery (ACA)
Number of subjects: 108
Study 36041790 — intervention group
Group type: EXPERIMENTAL
Intervention: HIF-prolyl-hydroxyl domain (PHD) inhibitors (roxadustat, vadadustat, daprodustat)
Number of subjects: 0
Study 36041790 — intervention group
Group type: COMPARATOR
Intervention: Erythropoiesis-stimulating agents (ESA)
Number of subjects: 0
Study 36041790 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33957393 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive management system with broiler and layers in Dodoma Municipal
Number of subjects: 400
Study 33957393 — intervention group
Group type: COMPARATOR
Intervention: Free-range management system with local breed chickens in Kongwa district
Number of subjects: 400
Study 33957393 — intervention group
Group type: EXPERIMENTAL
Intervention: Challenges in chicken production
Number of subjects: 400
Study 32067595 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric handgrip training (IHT)
Number of subjects: 0
Study 32067595 — intervention group
Group type: COMPARATOR
Intervention: Control group (compression ball)
Number of subjects: 0
Study 33274388 — intervention group
Group type: EXPERIMENTAL
Intervention: Early headgear activator treatment
Number of subjects: 60
Study 33274388 — intervention group
Group type: COMPARATOR
Intervention: Untreated control group (UG)
Number of subjects: 60
Study 32931641 — intervention group
Group type: EXPERIMENTAL
Intervention: Distal Roux‐en‐Y gastrojejunal bypass (DRYGJB)
Number of subjects: 140
Study 32931641 — intervention group
Group type: COMPARATOR
Intervention: Standard Roux‐en‐Y gastric bypass (RYGB)
Number of subjects: 140
Study 32931641 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (RYGB and DRYGJB)
Number of subjects: 140
Study 36168659 — intervention group
Group type: EXPERIMENTAL
Intervention: Masupirdine 50 mg
Number of subjects: 57
Study 36168659 — intervention group
Group type: EXPERIMENTAL
Intervention: Masupirdine 100 mg
Number of subjects: 57
Study 36168659 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study 33138630 — intervention group
Group type: EXPERIMENTAL
Intervention: Less social support at 9 months
Number of subjects: 1154
Study 33138630 — intervention group
Group type: EXPERIMENTAL
Intervention: Going without basic needs or healthcare at 9 months
Number of subjects: 1154
Study 32436830 — intervention group
Group type: COMPARATOR
Intervention: Intravenous reperfusion therapy (IVT)
Number of subjects: 917
Study 32436830 — intervention group
Group type: COMPARATOR
Intervention: Mechanical thrombectomy (MT)
Number of subjects: 917
Study 32436830 — intervention group
Group type: COMPARATOR
Intervention: Intravenous alteplase combined with mechanical thrombectomy (IAT)
Number of subjects: 917
Study 32436830 — intervention group
Group type: EXPERIMENTAL
Intervention: No cerebral reperfusion therapy (NCRT)
Number of subjects: 917
Study 35614019 — intervention group
Group type: COMPARATOR
Intervention: Video-based group (group 1)
Number of subjects: 33
Study 35614019 — intervention group
Group type: COMPARATOR
Intervention: Simulation-based group (group 2)
Number of subjects: 33
Study 35614019 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination group (group 3)
Number of subjects: 33
Study 35614019 — intervention group
Group type: EXPERIMENTAL
Intervention: 3rd-year residents in group 3
Number of subjects: 33
Study 35614019 — intervention group
Group type: EXPERIMENTAL
Intervention: 4th-year residents in group 3
Number of subjects: 33
Study 34744750 — intervention group
Group type: EXPERIMENTAL
Intervention: SHR-1222 (50 mg, n = 4; 100, 200, 300, or 400 mg, n = 9)
Number of subjects: 50
Study 34744750 — intervention group
Group type: COMPARATOR
Intervention: Placebo (10 subjects)
Number of subjects: 50
Study 34744750 — intervention group
Group type: EXPERIMENTAL
Intervention: SHR-1222
Number of subjects: 50
Study 35713444 — intervention group
Group type: EXPERIMENTAL
Intervention: Binaural beat music
Number of subjects: 112
Study 35713444 — intervention group
Group type: EXPERIMENTAL
Intervention: Plain music
Number of subjects: 112
Study 35713444 — intervention group
Group type: COMPARATOR
Intervention: No music
Number of subjects: 112
Study 32619223 — intervention group
Group type: EXPERIMENTAL
Intervention: ZnP (1.0 g/[hd · d] additional Zn)
Number of subjects: 32
Study 32619223 — intervention group
Group type: COMPARATOR
Intervention: CON (0.0 g/[hd · d] of additional Zn)
Number of subjects: 32
Study 32619223 — intervention group
Group type: COMPARATOR
Intervention: Not available
Number of subjects: 32
Study 35861826 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialysis vintage ≤12 months
Number of subjects: 241
Study 35861826 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialysis vintage >12 months
Number of subjects: 241
Study 32239460 — intervention group
Group type: EXPERIMENTAL
Intervention: Individually tailored counselling (one face-to-face session, four phone calls, and supportive written material)
Number of subjects: 204
Study 32239460 — intervention group
Group type: EXPERIMENTAL
Intervention: Individually tailored counselling
Number of subjects: 204
Study 32239460 — intervention group
Group type: COMPARATOR
Intervention: Written health information (control group)
Number of subjects: 204
Study 33500169 — intervention group
Group type: EXPERIMENTAL
Intervention: Aromatherapy (lavender essential oil)
Number of subjects: 172
Study 33500169 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 172
Study 34378247 — intervention group
Group type: EXPERIMENTAL
Intervention: Naftopidil (75 mg/day)
Number of subjects: 141
Study 34378247 — intervention group
Group type: COMPARATOR
Intervention: Silodosin (8 mg/day)
Number of subjects: 141
Study 35051971 — intervention group
Group type: EXPERIMENTAL
Intervention: Specialized outpatient physical therapy (PT) program
Number of subjects: 60
Study 35051971 — intervention group
Group type: COMPARATOR
Intervention: General outpatient PT referral (Control)
Number of subjects: 60
Study 35051971 — intervention group
Group type: EXPERIMENTAL
Intervention: Specialized outpatient PT program
Number of subjects: 60
Study 34448282 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadruple therapy
Number of subjects: 151
Study 34448282 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics supplemented quadruple therapy
Number of subjects: 151
Study 34448282 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics monotherapy
Number of subjects: 151
Study 32398065 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic stewardship programme implemented in intervention arm, including training for family physicians, improved management and peer-review of antibiotic prescribing, improved electronic medical records and smartphone app facilitation, patient education via family physicians, leaflets, and videos.
Number of subjects: 34
Study 32398065 — intervention group
Group type: COMPARATOR
Intervention: Usual care in control arm (no specific intervention details provided).
Number of subjects: 34
Study 35233617 — intervention group
Group type: EXPERIMENTAL
Intervention: SoC + remdesivir
Number of subjects: 665
Study 35233617 — intervention group
Group type: COMPARATOR
Intervention: SoC
Number of subjects: 665
Study 35796224 — intervention group
Group type: COMPARATOR
Intervention: Topical minoxidil 5% gel
Number of subjects: 50
Study 35796224 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical methotrexate 1% gel
Number of subjects: 50
Study 32755632 — intervention group
Group type: EXPERIMENTAL
Intervention: AIM HI training for therapists
Number of subjects: 202
Study 32755632 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 202
Study 32135136 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone 25 mg once daily
Number of subjects: 216
Study 32135136 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 216
Study 32135136 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk participants
Number of subjects: 216
Study 32135136 — intervention group
Group type: COMPARATOR
Intervention: Low-risk participants
Number of subjects: 216
Study 35750241 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental video (empowerment and participatory discourse)
Number of subjects: 589
Study 35750241 — intervention group
Group type: COMPARATOR
Intervention: Control video (disease and impairment discourse)
Number of subjects: 589
Study 35212635 — intervention group
Group type: EXPERIMENTAL
Intervention: Stratified blended physiotherapy (e-Exercise LBP)
Number of subjects: 208
Study 35212635 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face physiotherapy
Number of subjects: 208
Study 35212635 — intervention group
Group type: EXPERIMENTAL
Intervention: Stratified blended physiotherapy (e-Exercise LBP) in high-risk patients
Number of subjects: 208
Study 32064843 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium sulphate (CaS) used in layers to fill the socket after extraction
Number of subjects: 20
Study 32064843 — intervention group
Group type: COMPARATOR
Intervention: Control group with gauze and tranexamic acid placed in the extraction site
Number of subjects: 20
Study 35370712 — intervention group
Group type: EXPERIMENTAL
Intervention: Buyang Huanwu Decoction (BYHW)
Number of subjects: 80
Study 35370712 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 34474706 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous allergy immunotherapy for short ragweed, timothy grass, Dermatophagoides pteronyssinus, and cat and dog dander.
Number of subjects: 0
Study 34474706 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual allergy immunotherapy (approved tablets).
Number of subjects: 0
Study 34474706 — intervention group
Group type: EXPERIMENTAL
Intervention: U.S. liquid extracts for ragweed.
Number of subjects: 0
Study 34474706 — intervention group
Group type: EXPERIMENTAL
Intervention: General analysis of dosing practices by U.S. allergists.
Number of subjects: 0
Study 34114978 — intervention group
Group type: EXPERIMENTAL
Intervention: aprepitant in cART naïve individuals
Number of subjects: 57
Study 34114978 — intervention group
Group type: EXPERIMENTAL
Intervention: aprepitant in cART treated individuals
Number of subjects: 57
Study 34114978 — intervention group
Group type: COMPARATOR
Intervention: placebo in cART naïve individuals
Number of subjects: 57
Study 36083850 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous Transforaminal Endoscopic Discectomy (PTED)
Number of subjects: 241
Study 36083850 — intervention group
Group type: COMPARATOR
Intervention: Microendoscopic Discectomy (MED)
Number of subjects: 241
Study 36083850 — intervention group
Group type: EXPERIMENTAL
Intervention: PTED
Number of subjects: 241